|
|
 
|
- Baycol Recall
Baycol, also known as Cerivastatin is cholesterol lowering drug, recently withdrawn from United States markets because of reports of fatal rhabdomyolysis side effects, a severe muscle adverse reaction of the drug Baycol.
Baycol and Lipobay, generically known as Cerivastatin, were prescribed for treatment of hypercholesterolemia, (elevated cholesterol levels) which is a known risk factor for heart attack and coronary artery disease.
BAYCOL
On August 8, 2001 the FDA announced that Bayer Pharmaceutical Division will be voluntarily withdrawing Baycol (Cerivastatin) (also marketed under the name Lipobay) from markets in the United States. This shocking announcement came after numerous reports of sometimes fatal rhabdomyolysis, a severe muscle adverse reaction linked to their cholesterol-lowering product Baycol. The FDA agrees with and supports this decision.
- Guidant Defibrillator Product Recall
Daily Product Liability News from Online Lawyer Source including the Guidant Defibrillator Recall.
|
